|
Market Closed -
Nasdaq
20:00:00 27/10/2026 GMT
|
5-day change | 1st Jan Change | ||
| 0.7902 USD | +5.36% |
|
-31.88% | -28.81% |
| Market Cap | 24.34M 21.84M 20.17M 18.29M 34.18M 2.31B 34.6M 242M 96.04M 1.21B 91.36M 89.4M 3.84B | P/E 2024 |
-0.79x | P/E 2025 | -0.31x |
|---|---|---|---|---|---|
| Enterprise Value | 92.88M 83.36M 76.97M 69.8M 130M 8.82B 132M 923M 366M 4.62B 349M 341M 14.66B | EV / Sales 2024 |
2.12x | EV / Sales 2025 | 3.77x |
| Free-Float |
66.73% | Yield 2024 * |
-
| Yield 2025 | - |
NasdaqUSD
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| CELU | Delayed | |
CBOE
| CELU | Real-time |
| 1 day | +5.36% | ||
| 1 week | -31.88% | ||
| Current month | -41.47% | ||
| 1 month | -42.74% | ||
| 3 months | +5.36% | ||
| 6 months | -28.81% | ||
| Current year | -28.81% |
| 1 week | 0.66 |  | 1.31 |
| 1 month | 0.66 | | 1.8 |
| Current year | 0.56 | | 2.55 |
| 1 year | 0.56 | | 2.55 |
| 3 years | 0.56 | | 7.97 |
| 5 years | 0.56 | | 131.86 |
| 10 years | 0.56 | | 134 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 66 | 31/12/2015 | |
John Sprague
DFI | Director of Finance/CFO | 67 | 26/02/2026 |
K Fletcher
CMP | Compliance Officer | 42 | 30/06/2021 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 66 | 31/12/2015 | |
Peter Diamandis
BRD | Director/Board Member | 64 | 30/06/2017 |
Steven Gordon
BRD | Director/Board Member | 58 | 18/06/2026 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 23/09/26 | Others | 6,425,301 | 26.8288% | |||
| 23/09/26 | Others | Director | 6,425,301 | 26.8288% | ||
| 23/09/26 | Others | 6,425,301 | 26.8288% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +5.36% | -31.88% | -61.83% | -61.26% | 24.34M | |
| +0.22% | +3.35% | +55.30% | +125.65% | 1,140B | |
| +0.91% | +5.89% | +41.14% | +80.36% | 641B | |
| -0.12% | +1.31% | +25.62% | +97.24% | 507B | |
| +0.63% | +4.97% | +47.12% | +68.18% | 383B | |
| +0.86% | -1.26% | +62.10% | +34.36% | 347B | |
| +1.02% | +3.69% | +23.73% | +51.35% | 293B | |
| -0.25% | +3.40% | +2.31% | +23.38% | 266B | |
| +0.75% | +5.41% | +53.53% | +66.09% | 240B | |
| +0.25% | +3.93% | +31.54% | +102.65% | 197B | |
| Average | +1.00% | -0.90% | +28.06% | +58.80% | 401.38B | |
| Weighted average by Cap. | +0.55% | +2.98% | +42.01% | +84.56% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 54.22M 48.66M 44.93M 40.75M 76.15M 5.15B 77.09M 539M 214M 2.7B 204M 199M 8.56B | 26.55M 23.83M 22M 19.95M 37.29M 2.52B 37.75M 264M 105M 1.32B 99.66M 97.53M 4.19B |
| Net income | -57.89M -51.96M -47.98M -43.51M -81.31M -5.5B -82.31M -575M -228M -2.88B -217M -213M -9.14B | -91.72M -82.32M -76.01M -68.92M -129M -8.71B -130M -911M -362M -4.57B -344M -337M -14.48B |
| Net Debt | 68.1M 61.12M 56.43M 51.17M 95.65M 6.47B 96.82M 677M 269M 3.39B 256M 250M 10.75B | 68.54M 61.51M 56.8M 51.51M 96.26M 6.51B 97.45M 681M 270M 3.41B 257M 252M 10.82B |
Employees
115
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 27/10/26 | US$0.7902 | +5.36% | 219,290 |
| 26/10/26 | US$0.7500 | -23.29% | 629,002 |
| 23/10/26 | US$0.9777 | -6.89% | 145,347 |
| 22/10/26 | US$1.050 | +2.94% | 144,726 |
| 21/10/26 | US$1.020 | -19.05% | 204,708 |
Annual profits - Rate of surprise
- Stock Market
- Stocks
- CELU Stock
Select your edition
All financial news and data tailored to specific country editions
